Rilotumumab
id:
rilotumumab-252-6750316
title:
Rilotumumab
text:
Rilotumumab is a human monoclonal antibody designed for the treatment of solid tumors. Rilotumumab was in development by Amgen, Inc. until in November 2014, when Amgen announced it had halted all clinical trials of the compound in advanced gastric cancer after one of the trials found an increase in the number of deaths in those who were taking rilotumumab and chemotherapy when compared to those who were only administered chemotherapy.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Rilotumumab
date created:
date modified:
2023-05-19T15:28:46Z
main entity:
{"identifier":"Q7334301","url":"https://www.wikidata.org/entity/Q7334301"}
image:
fields total:
13
integrity:
14